The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Polymorphisms in DNA repair and metabolic genes in bladder cancer
Abstract
We investigated the association of urinary bladder cancer with genetic polymorphisms in the xeroderma pigmentosum complementation group C (XPC), group D (XPD) and group G (XPG), X-ray repair cross-complementing group 1 (XRCC1) and group 3 (XRCC3), Nijmegen breakage syndrome 1 (NBS1), cyclin D1, methylene-tetrahydrofolate reductase (MTHFR), NAD(P)H dehydrogenase quinone 1 (NQO1), H-ras and glutathione S-transferase theta 1 (GSTT1) genes. Bladder cancer patients from the different hospitals in Stockholm County Council area and matching controls were genotyped for different polymorphisms. The frequency of the variant allele for A/C polymorphism in exon 15 of the XPC gene was significantly higher in the bladder cancer cases than in the controls (OR 1.49, 95% CI 1.16-1.92, P = 0.001). The variant allele homozygote genotype for the T/C polymorphism in exon 1 of the H-ras gene was associated with a decreased risk for bladder cancer (OR 0.12, 95% CI 0.02-0.67, P = 0.006). The variant allele genotypes for the single nucleotide polymorphisms (SNPs) in DNA repair genes, XPG and NBS1, showed a marginal association with the occurrence of bladder cancer (OR 0.38, 95% CI 0.15-0.94, P = 0.03 and OR 1.64, 95% CI 0.92-2.90, P = 0.09, respectively). We also report a positive correlation between the null homozygote of GSTT1 with the risk of bladder cancer (OR 2.54, 95% CI 1.32-4.98, P = 0.003). For other polymorphisms included in this study, NBS1 Glu185Gln, XPD Lys751Gln, XPG Asp1104His, XRCC1 Arg399Gln, XRCC3 Thr241Met, cyclin D1 Pro242Pro, MTHFR Ala222Val and Glu429Ala, NQO1 Arg139Trp and Pro187Ser, no significant differences for genotype distributions and allele frequencies between the bladder cancer cases and the controls were observed in the present study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wood, R. D., Mitchell, M., Sgouros, J., & Lindahl, T. (2001) · Science · doi:10.1126/science.1056154 · Cited by 1,466
Polymorphisms in DNA repair genes and associations with cancer risk.
Goode, E. L., Ulrich, C. M., & Potter, J. D. (2002) · PubMed · Cited by 1,307
Friedberg, E. C. (2003) · Nature · doi:10.1038/nature01408 · Cited by 1,177
How nucleotide excision repair protects against cancer
Friedberg, E. C. (2001) · Nature Reviews Cancer · doi:10.1038/35094000 · Cited by 730
RESPONSE Re: Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
Berwick, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1537 · Cited by 545
Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells
Tauchi, H., Kobayashi, J., Morishima, K.-I., van Gent, D. C., Shiraishi, T., Verkaik, N. S., vanHeems, D., Ito, E., Nakamura, A., Sonoda, E., et al. (2002) · Nature · doi:10.1038/nature01125 · Cited by 283
Qiao, Y., Spitz, M. R., Shen, H., Guo, Z., Shete, S., Hedayati, M., Grossman, L., Mohrenweiser, H., & Wei, Q. (2002) · Carcinogenesis · doi:10.1093/carcin/23.2.295 · Cited by 264
Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review
Engel, L. S. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf018 · Cited by 245
Mohrenweiser, H. W., & Jones, I. M. (1998) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(98)00059-1 · Cited by 227
Epidemiology and Etiology of Premalignant and Malignant Urothelial Changes
Cohen, S. M., Shirai, T., & Steineck, G. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590050509869 · Cited by 191
Sugasawa, K., Shimizu, Y., Iwai, S., & Hanaoka, F. (2002) · DNA Repair · doi:10.1016/s1568-7864(01)00008-8 · Cited by 188
Khan, S. G. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf469 · Cited by 162
Variability in nucleotide excision repair and cancer risk: a review
Benhamou, S., & Sarasin, A. R. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00032-6 · Cited by 143
A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism
Khan, S. G. (2000) · Carcinogenesis · doi:10.1093/carcin/21.10.1821 · Cited by 142
The genetics of transitional cell carcinoma: progress and potential clinical application
Knowles, M. A. (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00217.x · Cited by 137
Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer
Wang, L., Habuchi, T., Takahashi, T., Mitsumori, K., Kamoto, T., Kakehi, Y., Kakinuma, H., Sato, K., Nakamura, A., Ogawa, O., et al. (2002) · Carcinogenesis · doi:10.1093/carcin/23.2.257 · Cited by 137
Shen, H., Sturgis, E. M., Khan, S. G., Qiao, Y., Shahlavi, T., Eicher, S. A., Xu, Y., Wang, X., Strom, S. S., Spitz, M. R., et al. (2001) · PubMed · Cited by 130
Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner
Sawa, H., Ohshima, T. A., Ukita, H., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201691 · Cited by 121
DNA bending by the human damage recognition complex XPC–HR23B
Janićijević, A., Sugasawa, K., Shimizu, Y., Hanaoka, F., Wijgers, N., Djurica, M., Hoeijmakers, J. H. J., & Wyman, C. (2003) · DNA repair · doi:10.1016/s1568-7864(02)00222-7 · Cited by 107
Stern, M. C., Umbach, D. M., Lunn, R. M., & Taylor, J. A. (2002) · PubMed · Cited by 101
Kumar, R., Höglund, L., Zhao, C., Försti, A., Snellman, E., & Hemminki, K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10870 · Cited by 97
Molecular Genetics of Cancer Susceptibility
Brockmöller, J., Cascorbi, I., Henning, S. W., Meisel, C., & Roots, I. (2000) · Pharmacology · doi:10.1159/000028403 · Cited by 74
Allelic Variation of Reporter Gene Activation by the HRAS1 Minisatellite
Green, M., & Krontiris, T. G. (1993) · Genomics · doi:10.1006/geno.1993.1343 · Cited by 64
Ponder, B. A. J. (1992) · BMJ · doi:10.1136/bmj.304.6836.1234 · Cited by 63
p53 mutations in urinary bladder cancer
Berggren, P., Steineck, G., Adolfsson, J., Hansson, J., JANSSON, O. T., Larsson, P., Sandstedt, B., Wijkström, H., & Hemminki, K. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1823 · Cited by 58
Johne, A., Roots, I., & Brockmöller, J. (2003) · PubMed · Cited by 39
Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene
Sakano, S., Berggren, P., Kumar, R., Steineck, G., Adolfsson, J., Onelöv, E., Hemminki, K., & Larsson, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.10919 · Cited by 35
Cited by
García-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D. W., Tardón, A., Serra, C., Carrato, A., García-Closas, R., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67137-1 · Cited by 627
Genetic Polymorphisms in the Base Excision Repair Pathway and Cancer Risk: A HuGE Review
Hung, R. J., Hall, J., Brennan, P., & Boffetta, P. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi318 · Cited by 525
Epidemiology of male breast cancer
Konduri, S., Singh, M., Bobustuc, G., Rovin, R., & Kassam, A. (2020) · The Breast · doi:10.1016/j.breast.2020.08.010 · Cited by 411
Cyclin D1: polymorphism, aberrant splicing and cancer risk
Knudsen, K. E., Diehl, J. A., Haiman, C. A., & Knudsen, E. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209371 · Cited by 363
Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer
Broberg, K., Björk, J., Paulsson, K., Höglund, M., & Albin, M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi063 · Cited by 255
Metadata
- Authors
- Sanyal, S.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-12-19
- Volume
- 25
- Issue
- 5
- Pages
- 729-734
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2109951137
- Cited by
- 339
- References
- 27
- FWCI
- 12.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.